Ali Mehdi

For pharma’s sake, drug regulatory agencies need to cooperate

The pharmaceutical Sector in India is at the crossroads. Having established itself as the world leader in the space of generics—accounting for one-fifth of the global generic export volume (IBEF)—it has begun to take the

Glenmark Pharmaceuticals, US health regulator, IND, USFDA, Kurt Stoeckli, DNA-derived, IMS sales data, BSE News

Healthcare: Narendra Modi govt does well to think of door-to-door screening for cancer, diabetes

The government has done well to think about door-to-door screening for cancer, heart disorders and diabetes given the rise in premature deaths

Health News

The Indian health challenge : What ails India’s workers

The first step is to admit the health challenges. Only then will we start thinking of ways to address them

The Indian health challenge : What ails India’s workers

India need a medical commission at central and state levels; Here’s why

The country is in dire need of both national and state level medical commissions

Opinion News

Why chronic diseases crisis in India must be tackled now

We need to prioritise public health allocations and reduce budgetary inefficiencies

Why chronic diseases crisis in India must be tackled now

Making healthcare affordable in India

Much before the Union Budget was unveiled, Indian pharmaceutical and medical device manufacturers were granted significant competitive privileges over their foreign counterparts.

Making healthcare affordable in India
Switch to Hindi Edition